NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Massachusetts faced some of the heaviest losses nationally, with cuts affecting more than $100 million in NIH grants.

News about an outbreak or mystery virus can trigger fear. Use four questions to assess whether the reports are something to ...

The Indiana Department of Health (IDOH) is reporting the first laboratory confirmed case of measles in Indiana this year. The ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Gilead Sciences, Inc. today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, May 7-10, 2025, Amsterdam, furthering Gilead's commitment to ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...